Furthermore, Xlf−/− B cells perform V(D)J recombination at almost wild-type levels, which explains the lack of significant immunodeficiency in these mice and suggests that compensatory mechanisms can mitigate loss of XLF in developing lymphocytes. This evidence concerns the gene NHEJ1 and immune system disorder.